Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) EBT Margin (2016 - 2026)

Biomerica's EBT Margin history spans 17 years, with the latest figure at 132.12% for Q1 2026.

  • Quarterly results put EBT Margin at 132.12% for Q1 2026, down 2783.0% from a year ago — trailing twelve months through Feb 2026 was 96.0% (down 1065.0% YoY), and the annual figure for FY2025 was 93.62%, up 1600.0%.
  • EBT Margin for Q1 2026 was 132.12% at Biomerica, down from 108.68% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 0.36% in Q3 2025 to a low of 205.47% in Q2 2025.
  • The 5-year median for EBT Margin is 108.68% (2025), against an average of 101.92%.
  • The sharpest move saw EBT Margin skyrocketed 12921bps in 2022, then plummeted -14404bps in 2023.
  • Year by year, EBT Margin stood at 109.65% in 2022, then grew by 13bps to 95.66% in 2023, then surged by 39bps to 58.25% in 2024, then crashed by -87bps to 108.68% in 2025, then dropped by -22bps to 132.12% in 2026.
  • According to Business Quant data, EBT Margin over the past three periods came in at 132.12%, 108.68%, and 0.36% for Q1 2026, Q4 2025, and Q3 2025 respectively.